Inflazome (inflazome.com), the pioneering inflammasome biotech company developing multiple small molecule drugs that block harmful inflammation, today announces that the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO) will grant the patent application WO 2016/131098 as US 10,538,487 on 21 January 2020 and EP 3,259,253 on 15 January … [Read more...] about Inflazome IP Portfolio Strengthened with Patents Granted in US and Europe
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Market Intelligence
Footer
Blockchaining
- Global Venture Funding for Blockchain and Crypto Companies Hit Record $26.8B in 2022, But Declined in Later Quarters
- Unlocking the Power of Engagement: Exploring the Connection between Gamification and Blockchaining
- Building a Decentralized VPN Using Blockchain Technology
- Exploring the Latest Innovations in Blockchain and Crypto: A Report from the European Blockchain Convention 2023
- Cryptocurrency has become a global phenomenon with a market capitalization of almost $3 trillion at its peak in November 2021
OPINT
- Agile Requirements Gathering and User Story Mapping
- OPINT: Exploring the Intersection of Operational Intelligence and Gaming in the Defense Industry
- Russia says will cut crude production by 5% next month
- President Xi Jinping’s long-term economic ambitions are out of reach
- The South China Sea (SCS) and East China Sea (ECS) are becoming a major area of competition between the US and China